149 related articles for article (PubMed ID: 22425267)
1. Age and mental health predict early device-specific quality of life in patients receiving prophylactic implantable defibrillators.
Carroll SL; Markle-Reid M; Ciliska D; Connolly SJ; Arthur HM
Can J Cardiol; 2012; 28(4):502-7. PubMed ID: 22425267
[TBL] [Abstract][Full Text] [Related]
2. Disease-specific quality of life-patient acceptance: racial and gender differences in patients with implantable cardioverter defibrillators.
Wilson MH; Engelke MK; Sears SF; Swanson M; Neil JA
J Cardiovasc Nurs; 2013; 28(3):285-93. PubMed ID: 22580627
[TBL] [Abstract][Full Text] [Related]
3. Correlates of patient acceptance of the cardioverter defibrillator: cross-validation of the Florida Patient Acceptance Survey in Danish patients.
Pedersen SS; Spindler H; Johansen JB; Mortensen PT; Sears SF
Pacing Clin Electrophysiol; 2008 Sep; 31(9):1168-77. PubMed ID: 18834469
[TBL] [Abstract][Full Text] [Related]
4. Monitoring device acceptance in implantable cardioverter defibrillator patients using the Florida Patient Acceptance Survey.
Versteeg H; Starrenburg A; Denollet J; Palen Jv; Sears SF; Pedersen SS
Pacing Clin Electrophysiol; 2012 Mar; 35(3):283-93. PubMed ID: 22229519
[TBL] [Abstract][Full Text] [Related]
5. Do patients accept implantable atrial defibrillation therapy? Results from the Patient Atrial Shock Survey of Acceptance and Tolerance (PASSAT) Study.
Burns JL; Sears SF; Sotile R; Schwartzman DS; Hoyt RH; Alvarez LG; Ujhelyi MR
J Cardiovasc Electrophysiol; 2004 Mar; 15(3):286-91. PubMed ID: 15030417
[TBL] [Abstract][Full Text] [Related]
6. General and disease-specific psychosocial adjustment in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy with implantable cardioverter defibrillators: a large cohort study.
James CA; Tichnell C; Murray B; Daly A; Sears SF; Calkins H
Circ Cardiovasc Genet; 2012 Feb; 5(1):18-24. PubMed ID: 22238189
[TBL] [Abstract][Full Text] [Related]
7. Measuring patient acceptance of implantable cardiac device therapy: initial psychometric investigation of the Florida Patient Acceptance Survey.
Burns JL; Serber ER; Keim S; Sears SF
J Cardiovasc Electrophysiol; 2005 Apr; 16(4):384-90. PubMed ID: 15828880
[TBL] [Abstract][Full Text] [Related]
8. Patient-assisted computerized education for recipients of implantable cardioverter defibrillators: a randomized controlled trial of the PACER program.
Kuhl EA; Sears SF; Vazquez LD; Conti JB
J Cardiovasc Nurs; 2009; 24(3):225-31. PubMed ID: 19390340
[TBL] [Abstract][Full Text] [Related]
9. The impact of technology dependency on device acceptance and quality of life in persons with implantable cardioverter defibrillators.
Udlis KA
J Cardiovasc Nurs; 2013; 28(6):E65-73. PubMed ID: 23348222
[TBL] [Abstract][Full Text] [Related]
10. Clustering of poor device acceptance and Type D personality is associated with increased distress in Danish cardioverter-defibrillator patients.
Pedersen SS; Spindler H; Johansen JB; Mortensen PT
Pacing Clin Electrophysiol; 2009 Jan; 32(1):29-36. PubMed ID: 19140910
[TBL] [Abstract][Full Text] [Related]
11. Quality of life among implantable cardioverter-defibrillator recipients in the primary prevention therapeutic era.
Groeneveld PW; Matta MA; Suh JJ; Yang F; Shea JA
Pacing Clin Electrophysiol; 2007 Apr; 30(4):463-71. PubMed ID: 17437568
[TBL] [Abstract][Full Text] [Related]
12. An updated review of implantable cardioverter/defibrillators, induced anxiety, and quality of life.
Bostwick JM; Sola CL
Psychiatr Clin North Am; 2007 Dec; 30(4):677-88. PubMed ID: 17938040
[TBL] [Abstract][Full Text] [Related]
13. Posttraumatic stress symptoms and predicted mortality in patients with implantable cardioverter-defibrillators: results from the prospective living with an implanted cardioverter-defibrillator study.
Ladwig KH; Baumert J; Marten-Mittag B; Kolb C; Zrenner B; Schmitt C
Arch Gen Psychiatry; 2008 Nov; 65(11):1324-30. PubMed ID: 18981344
[TBL] [Abstract][Full Text] [Related]
14. Predictors of quality of life in patients with implantable cardioverter defibrillators.
Sears SF; Lewis TS; Kuhl EA; Conti JB
Psychosomatics; 2005; 46(5):451-7. PubMed ID: 16145190
[TBL] [Abstract][Full Text] [Related]
15. The Registry Evaluating Functional Outcomes of Resynchronization Management (REFORM): quality of life and psychological functioning in patients receiving cardiac resynchronization therapy.
Ford J; Sears S; Ramza B; Reynolds DW; Nguyen P; Fedewa M; House J; Kennedy P; Thompson R; Murray C
J Cardiovasc Electrophysiol; 2014 Jan; 25(1):43-51. PubMed ID: 24102945
[TBL] [Abstract][Full Text] [Related]
16. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.
Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S
Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108
[TBL] [Abstract][Full Text] [Related]
17. Gender differences in anxiety and concerns about the cardioverter defibrillator.
Spindler H; Johansen JB; Andersen K; Mortensen P; Pedersen SS
Pacing Clin Electrophysiol; 2009 May; 32(5):614-21. PubMed ID: 19422582
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life consequences of implantable cardioverter defibrillators: results from MADIT II.
Noyes K; Corona E; Zwanziger J; Hall WJ; Zhao H; Wang H; Moss AJ; Dick AW;
Med Care; 2007 May; 45(5):377-85. PubMed ID: 17446823
[TBL] [Abstract][Full Text] [Related]
19. Characteristics associated with anxiety, depressive symptoms, and quality-of-life in a large cohort of implantable cardioverter defibrillator recipients.
Thylén I; Dekker RL; Jaarsma T; Strömberg A; Moser DK
J Psychosom Res; 2014 Aug; 77(2):122-7. PubMed ID: 25077853
[TBL] [Abstract][Full Text] [Related]
20. Quality of life in pediatric patients with implantable cardioverter defibrillators.
Sears SF; Hazelton AG; St Amant J; Matchett M; Kovacs A; Vazquez LD; Fairbrother D; Redfearn S; Hanisch D; Dubin A; Cannon BC; Fishbach P; Kanter R; Bryant RM
Am J Cardiol; 2011 Apr; 107(7):1023-7. PubMed ID: 21256464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
